Insulet Corporation
(NASDAQ: PODD)

Insulet Corporation is engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (the OmniPod System). The OmniPod System is an insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the Company's handheld, wireless Personal Diabetes Manager (PDM). The OmniPod Insulin Management System is designed to provide people with insulin-dependent diabetes with a diabetes management solution which provides lifestyle and other benefits and to expand the use of continuous subcutaneous insulin infusion (CSII) therapy. The OmniPod operates up to 72 hours (but no more than 80 hours) after it is activated.

315.920 s

+8.360 (+2.72%)
Range 305.050 - 317.340   (4.03%)
Open 308.780
Previous Close 307.560
Bid Price 292.570
Bid Volume 9
Ask Price 292.950
Ask Volume 8
Volume 747,412
Value -
Remark s
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events

About Insulet

Insulet Corporation is engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (the OmniPod System). The OmniPod System is an insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the Company's handheld, wireless Personal Diabetes Manager (PDM). The OmniPod Insulin Management System is designed to provide people with insulin-dependent diabetes with a diabetes management solution which provides lifestyle and other benefits and to expand the use of continuous subcutaneous insulin infusion (CSII) therapy. The OmniPod operates up to 72 hours (but no more than 80 hours) after it is activated.

Loading Chart...

Please login to view stock data and analysis